Literature DB >> 11306881

Radiotherapy for PSA recurrence after radical prostatectomy.

L Vanuytsel1, G Janssens, H Van Poppel, A Rijnders, L Baert.   

Abstract

OBJECTIVES: The treatment of patients presenting with an isolated PSA recurrence after radical prostatectomy (RP) remains controversial. The present study aims at assessing the results of salvage radiotherapy (RT), to define prognostic factors and to identify subgroups of patients most suitable for RT with curative intent.
MATERIALS AND METHODS: A retrospective study was performed of 53 patients, diagnosed with a rising PSA after RP, and treated with RT to the prostate bed, between July 1992 and July 1998.
RESULTS: On univariate analysis, significant determinants to obtain and maintain a nondetectable PSA (< 0.02 ng/ml) were Gleason grade (< or = III vs. < or = IV), pre-RT PSA, considered as categorical or continuous variable, and pathological stage, pT (2 vs. 3). Pre-RP PSA (< or = 10 vs. >10), time interval between surgery and moment of rising PSA and pathological section margin status were not significant. On multivariate analysis, only Gleason grade and pre-RT PSA remained significant. For the patient group with a Gleason grade < or = III the PSA-free survival at 3 years was 75% (+/- 11%) compared to 27% (+/- 9%) for the patients with a Gleason grade > or = IV (p = 0.002). Pre-RT PSA significantly influenced PSA-free survival in the first group, but not in the latter.
CONCLUSION: From the group of RP patients with rising PSA following a postsurgery PSA-free period, subgroups can be defined with a distinctly different probability of obtaining and maintaining nondetectable PSA levels after salvage RT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306881     DOI: 10.1159/000052480

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  4 in total

1.  Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

Authors:  Michael Sia; Tom Pickles; Gerard Morton; Louis Souhami; Himu Lukka; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

2.  Opinions from the experts: exploring what prostate cancer patients should know about post-operative radiotherapy.

Authors:  Laura D'Alimonte; Kaitlin Koo; Emily Chen; Deb Feldman-Stewart; Arlene Court; Margaret Fitch; Lisa Di Prospero; John Maamoun; Alex Kiss; Ewa Szumacher
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

Review 3.  Salvage radiotherapy following radical prostatectomy.

Authors:  Charles Catton; Michael Milosevic
Journal:  World J Urol       Date:  2003-08-16       Impact factor: 4.226

4.  Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience.

Authors:  Laurent Quero; Pierre Mongiat-Artus; Vincent Ravery; Claude Maylin; François Desgrandchamps; Christophe Hennequin
Journal:  BMC Cancer       Date:  2008-01-29       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.